Form 8-K - Current report:
SEC Accession No. 0001654954-25-003608
Filing Date
2025-03-31
Accepted
2025-03-31 08:39:27
Documents
15
Period of Report
2025-03-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K canna_8k.htm   iXBRL 8-K 29486
  Complete submission text file 0001654954-25-003608.txt   154162

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA canna-20250326.xsd EX-101.SCH 5882
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE canna-20250326_lab.xml EX-101.LAB 14667
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE canna-20250326_cal.xml EX-101.CAL 901
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE canna-20250326_pre.xml EX-101.PRE 9278
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE canna-20250326_def.xml EX-101.DEF 2102
17 EXTRACTED XBRL INSTANCE DOCUMENT canna_8k_htm.xml XML 3905
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

EIN.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27055 | Film No.: 25789103
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)